ResearcherThe University of Texas MD Anderson Cancer CenterActive in the last 2 years
Nilgün Gürbüz
Matched on ORCID iD 0000-0003-4476-5593; OpenAlex author ID A5030443996. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 2, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 5
2014: 2 papers · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: 1 paper · 2025: 1 paper
Papers 6
- Comparison of therapeutic potential of macrophage- or mesenchymal stem cell-derived exosomes in pancreatic cancer: An updated review. First author DOI 10.4252/wjsc.v17.i8.107400↗
- Anti-tumorigenic effects of naive and TLR4-primed adipose-derived mesenchymal stem cells on pancreatic ductal adenocarcinoma cells. Last author DOI 10.1002/cam4.6964↗
- miRNA-193b-5p Suppresses Pancreatic Cancer Cell Proliferation, Invasion, Epithelial Mesenchymal Transition, and Tumor Growth by Inhibiting eEF2K. Co-author DOI 10.2174/1871520622666220117123213↗
- MicroRNA-based Targeted Therapeutics in Pancreatic Cancer. Co-author DOI 10.21873/anticanres.13144↗
- Elongation factor-2 kinase regulates TG2/β1 integrin/Src/uPAR pathway and epithelial-mesenchymal transition mediating pancreatic cancer cells invasion. First author DOI 10.1111/jcmm.12361↗
- Down-regulation of 5-HT1B and 5-HT1D receptors inhibits proliferation, clonogenicity and invasion of human pancreatic cancer cells. Co-author DOI 10.1371/journal.pone.0105245↗
Closest collaborators
The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Demet Kaçaroğlu · 2 shared papers, 2024–2025 · strength 0.90
- Paper Comparison of therapeutic potential of macrophage- or mesenchymal stem cell-derived exosomes in pancreatic cancer: An u… DOI 10.4252/wjsc.v17.i8.107400↗
- Paper Anti-tumorigenic effects of naive and TLR4-primed adipose-derived mesenchymal stem cells on pancreatic ductal adenocarc… DOI 10.1002/cam4.6964↗
- Seher Yaylacı · 1 shared paper, 2024 · strength 0.36
- Bülent Özpolat · 3 shared papers, 2014–2019 · strength 0.31
- Paper MicroRNA-based Targeted Therapeutics in Pancreatic Cancer. DOI 10.21873/anticanres.13144↗
- Paper Down-regulation of 5-HT1B and 5-HT1D receptors inhibits proliferation, clonogenicity and invasion of human pancreatic c… DOI 10.1371/journal.pone.0105245↗
- Paper Elongation factor-2 kinase regulates TG2/β1 integrin/Src/uPAR pathway and epithelial-mesenchymal transition mediating p… DOI 10.1111/jcmm.12361↗
- Bulent Ozpolat · 1 shared paper, 2022 · strength 0.19
- Ahmed Amine Ashour · 2 shared papers, 2014 · strength 0.11
- Paper Down-regulation of 5-HT1B and 5-HT1D receptors inhibits proliferation, clonogenicity and invasion of human pancreatic c… DOI 10.1371/journal.pone.0105245↗
- Paper Elongation factor-2 kinase regulates TG2/β1 integrin/Src/uPAR pathway and epithelial-mesenchymal transition mediating p… DOI 10.1111/jcmm.12361↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.